CivicScience has data on more than 170K current GLP-1 users, providing a unique lens into these medications societal, cultural, and economic impact
That stigma, along with fear of another painful flare, can increase stress and contribute to more inflammation in your body
Deficiencia de Levocarnitina en pacientes sometidos a dilisis repetidas, Fibroelastosis subendocrdica
The rise (and rise) of GLP-1s GLP-1s (short for glucagon-like peptide-1 receptor agonists) are a class of medications originally developed for people with type 2 diabetes
Animal sources include, for example, fresh liver
Participants taking semaglutide or tirzepatide reported significantly lower alcohol intake, fewer drinks per episode, and lower binge drinking odds compared to before starting medication